Rovira J - Search Results

1

Assessing the economic impact of adverse drug effects.

Rodríguez-Monguió R, Otero MJ, Rovira J. Rodríguez-Monguió R, et al. Among authors: rovira j. Pharmacoeconomics. 2003;21(9):623-50. doi: 10.2165/00019053-200321090-00002. Pharmacoeconomics. 2003. PMID: 12807365 Review.

2

Transparency of economic evaluations of health technologies.

Rovira J. Rovira J. Pharmacoeconomics. 2008;26(3):181-3. doi: 10.2165/00019053-200826030-00002. Pharmacoeconomics. 2008. PMID: 18282013 No abstract available.

3

The cost of generalized anxiety disorder in primary care settings: results of the ANCORA study.

Rovira J, Albarracin G, Salvador L, Rejas J, Sánchez-Iriso E, Cabasés JM. Rovira J, et al. Community Ment Health J. 2012 Jun;48(3):372-83. doi: 10.1007/s10597-012-9503-4. Epub 2012 Apr 8. Community Ment Health J. 2012. PMID: 22484993

4

Economic evaluation of triflusal and aspirin in the treatment of acute myocardial infarction.

Darbà J, Izquierdo I, Pontes C, Navas C, Rovira J. Darbà J, et al. Among authors: rovira j. Pharmacoeconomics. 2002;20(3):195-201. doi: 10.2165/00019053-200220030-00005. Pharmacoeconomics. 2002. PMID: 11929349 Clinical Trial.

5

[Costs of health care resources of ambulatory-care patients diagnosed with Alzheimer's disease in Spain].

Boada M, Peña-Casanova J, Bermejo F, Guillén F, Hart WM, Espinosa C, Rovira J. Boada M, et al. Among authors: rovira j. Med Clin (Barc). 1999 Nov 27;113(18):690-5. Med Clin (Barc). 1999. PMID: 10650570 Spanish.

6

Cost-effectiveness analysis of hepatitis B vaccination strategies in Catalonia, Spain.

Antoñanzas F, Garuz R, Rovira J, Antón F, Trinxet C, Navas E, Salleras L. Antoñanzas F, et al. Among authors: rovira j. Pharmacoeconomics. 1995 May;7(5):428-43. doi: 10.2165/00019053-199507050-00007. Pharmacoeconomics. 1995. PMID: 10155330

7

[A cost-efficacy analysis of treatment with antiendotoxin monoclonal antibodies in gram-negative sepsis].

Badía X, Segú L, García Alonso F, Rovira J. Badía X, et al. Among authors: rovira j. Med Clin (Barc). 1993 Jan 23;100(3):84-9. Med Clin (Barc). 1993. PMID: 8426499 Spanish.

8

[Economic evaluation of prophylaxis with recombinant granulopoiesis stimulating factor].

Antoñanzas F, Rovira J, Garuz R, Antón F. Antoñanzas F, et al. Among authors: rovira j. Med Clin (Barc). 1992 Nov 28;99(18):685-9. Med Clin (Barc). 1992. PMID: 1282638 Spanish.

9

[The cost of arterial hypertension in Spain].

Badía X, Rovira J, Tresserras R, Trinxet C, Segú JL, Pardell H. Badía X, et al. Among authors: rovira j. Med Clin (Barc). 1992 Dec 12;99(20):769-73. Med Clin (Barc). 1992. PMID: 1369787 Spanish.

10

[Costs of known diabetes mellitus in Spain].

Hart WM, Espinosa C, Rovira J. Hart WM, et al. Among authors: rovira j. Med Clin (Barc). 1997 Sep 13;109(8):289-93. Med Clin (Barc). 1997. PMID: 9379750 Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results